Balance Sheets (USD $)	Jul. 31, 2013	Jul. 31, 2012
Current assets
Cash and cash equivalents	$ 598,623	$ 20,423
Prepaid insurance	21,250
Total current assets	619,873	20,423
Other assets
Patents and patent applications (net of accumulated amortization of $4,270 at July 31, 2013 and $2,897 at July 31, 2012)	23,180	24,553
Total assets	643,053	44,976
Current liabilities:
Accounts payable and accrued liabilities	40,767	55,497
Accrued salaries and wages	457,636	56,300
Due to related party	350,000	136,412
Convertible notes payable, net of debt discounts	25,000	223,693
Derivative liability	9,666	191,792
Total current liabilities	883,069	663,694
Deferred revenue	750,000
Total liabilities	1,633,069	663,694
Stockholders' equity (deficit)
Common stock; par value $0.001; 200,000,000 shares authorized; 164,699,973 shares issued and outstanding at July 31, 2013 and 126,083,416 shares issued and outstanding at July 31, 2012	164,700	126,083
Additional paid-in capital	27,429,672	23,184,094
Accumulated deficit during the development stage	(28,584,388)	(23,928,895)
Total stockholders' equity (deficit)	(990,016)	(618,718)
Total liabilities and stockholders' equity (deficit)	$ 643,053	$ 44,976